CT severity score: an imaging biomarker to estimate the severity of COVID-19 pneumonia in vaccinated and non-vaccinated population

BACKGROUND: In India, two vaccines received emergent use authorization, namely Covishield (a brand of the Oxford—Astra Zeneca vaccine manufactured by the Serum institute of India) and Covaxin (developed by Bharat Biotech) against COVID-19 disease. Chest CT is an objective way to assess the extent of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurumurthy, Balasubramanian, Das, Sudha Kiran, Shetty, Sachin, Veerabhadrappa, Rakesh Chowkalli, Kosinepalli, Sai Siddartha, Dharamaraju, Swathi Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003164/
http://dx.doi.org/10.1186/s43055-022-00768-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003164/
http://dx.doi.org/10.1186/s43055-022-00768-2

Ejemplares similares